Clinical observations document improvements in hair count, hair diameter, and overall scalp coverage in subjects using GHK-Cu for androgenetic alopecia, though the peptide's effectiveness appears optimized when applied consistently over several months
May 30, June 6 & June 13, 10am - 12pm PT/1 - 3pm ET 100% virtual Max 15 participants This is a small support group for people navigating GLP-1 fatigue or burnout
Let us bring hydration, energy, and wellness straight to you
Key differences include: Tirzepatide (Zepbound/Mounjaro): Dual-action on GIP and GLP-1 receptors Demonstrated superior effectiveness in significant weight loss Approved for obesity treatment under the Zepbound brand Administered once weekly via injection Ozempic and Wegovy: contains semaglutide, targeting only the GLP-1 receptor Wegovy is FDA-approved specifically for weight loss at higher doses Ozempic is used at lower doses, but also promotes weight reduction Administered once weekly via injection At JosephCareRX, we personalize weight loss treatment plans based on these differences to provide the safest and most effective approach tailored to each patients goals and needs
Your transformation doesnt happen overnight, but each week brings you closer to your healthiest, most confident self
Extension data to 104 weeks shows 30.3% average weight loss